DKSH and BridgeBio Partner to Expand ATTR-CM Treatment Access
SINGAPORE, June 11, 2026 DKSH Healthcare and BridgeBio have entered into a strategic distribution and commercialization partnership aimed at...
oral therapy
Advertisement
Takeda’s Zasocitinib Outperforms Deucravacitinib in Psoriasis
STOCKHOLM, Sweden, June 11OSAKA, Japan and CAMBRIDGE, Massachusetts, June 11, 2026, 2026 Takeda has announced positive topline results from...
Septerna Initiates SEP-479 Phase 1 Hypoparathyroidism
SOUTH SAN FRANCISCO, Calif., April 13, 2026 Septerna, Inc. has announced the initiation of its Phase 1 clinical trial...
Enanta Pharma Advances EDP-978 Phase 1 Urticaria Drug
WATERTOWN, Mass., April 13, 2026 Enanta Pharmaceuticals, Inc. has announced the first participant dosing in its Phase 1 clinical...
TML-6 Advances to Global Phase 2 Alzheimer’s Trials
TAINAN, Taiwan, Feb. 9, 2026 — MerryLife Biomedical Inc. announced positive Phase 1 clinical findings for TML-6, its investigational...
Advertisements
Pharvaris Unveils Breakthrough Oral Therapy for HAE Relief
ZUG, Switzerland, November 10, 2025 — Pharvaris N.V. (Nasdaq: PHVS), a late-stage biopharmaceutical company developing oral bradykinin B2 receptor...
50,000 + Uses of the Syn-One Test® Mark Major Diagnostic Milestone
Scottsdale, AZ — November 6, 2025 : CND Life Sciences (CND) announced the completion of its 50,000th Syn-One Test®,...
KalVista Pharmaceuticals Highlights EKTERLY®’s Promise for Children and Strong Patient Satisfaction in HAE Treatment
Framingham, Massachusetts & Salisbury, England — November 6, 2025 : KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) presented new data at...
Phibro Animal Health Licenses Novel Periodontal Therapy for Dogs
TEANECK, N.J., October 9, 2025 — Phibro Animal Health Corporation (NASDAQ: PAHC) announced a licensing agreement with Lighthouse Pharmaceuticals,...
FDA Approves Paltusotine as First Oral Therapy for Acromegaly
SAN DIEGO, Sept. 25, 2025 — The U.S. Food and Drug Administration (FDA) has approved PALSONIFY™ (paltusotine) as the...
Advertisement
